I have to agree with you ANP doesn’t have expert in the management to chase this kind of opportunity despite we have been told our drug had an excellent results in the USA together with a pathology company which I cannot remember the name. So question for ITSA how can you explain the fact the elected management is no where to be seen in this pathology in his own country? Curious to read your comment.
